Research feed

Latest Diabetes Research

Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.

Sorted by publication date. Some studies may have been added to Dediabetes later.

Last updated: Aug 22, 2026816 studies indexed

July 2026

Published Jul 12, 2026RCTs

SGLT2 inhibitors reduce cardiovascular events in diabetes

This study compared the real-world effectiveness of SGLT2 inhibitors and DPP4 inhibitors in patients with type 2 diabetes and cardiovascular disease, finding that SGLT2 inhibitors were associated with lower risks of major adverse cardiovascular events.

Interventions
SGLT2 inhibitors
Outcomes
All-cause mortalityComposite cardiovascular events (CV death, MI, stroke, HF hospitalization)Heart failure hospitalizations+1 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

SMS Messaging Improves Medication Adherence in Type 2 Diabetes

This pilot randomized controlled trial evaluated the feasibility of using SMS messaging to enhance medication adherence in individuals with Type 2 diabetes.

Interventions
SMS text messaging behavioral intervention for health promotion
Outcomes
HbA1cMedical record data availability at 6 monthsParticipant retention at 6 months+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

Telehealth Exercise Improves Function and Sleep in Type 2 Diabetes

This study evaluated a synchronous telehealth exercise program's impact on adults with Type 2 diabetes, finding significant improvements in various functional outcomes.

Interventions
Synchronous telehealth exercise program
Outcomes
Blood glucoseDepression scoreFunctional Performance Measured by Arm Curl Test+5 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

Text Messaging Improves Patient-Reported Outcomes in Diabetes Care

This study evaluated the impact of a text messaging intervention on patient-reported outcomes in individuals with Type 2 diabetes, finding significant improvements in various health-related measures.

Interventions
SMS text messaging behavioral intervention for health promotion
Outcomes
Diabetes knowledgeDiabetes management self-efficacyDiabetes self-management behaviors+6 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

Vitamin D supplementation shows little effect on glycemic control in type 2 diabetes

This study investigated the effects of vitamin D supplementation on glycemic control in newly diagnosed type 2 diabetes patients. No significant differences were found between the vitamin D group and the standard anti-diabetic drugs group.

Interventions
Standard anti-diabetic drugs onlyVitamin D supplementation
Outcomes
Fasting blood sugar (FBS)Fasting insulin levelsGlucose iAUC (OGTT)+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

Zinc supplementation improves glycemic control in newly diagnosed T2DM patients

This study examined the effects of zinc supplementation on glycemic control and lipid profiles in newly diagnosed type 2 diabetes patients, finding significant reductions in fasting plasma glucose and cholesterol levels.

Interventions
Zinc supplementation
Outcomes
Erythrocyte sedimentation rateFasting Plasma Glucose (FPG)Glucose iAUC (OGTT)+6 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

Digital intervention improves glycemic control in type 2 diabetes patients

This study evaluated the efficacy of a digital educational intervention for patients with Type 2 diabetes, finding significant improvements in various health metrics.

Interventions
Digital-based lifestyle interventionUsual care
Outcomes
BMIBody weightChange in EsDQOL satisfaction score+3 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

Digital-Driven Model Improves Diabetes Management in Underresourced Areas

This study evaluated a digital-driven physician-pharmacist collaborative model for managing Type 2 diabetes in underresourced settings, finding significant improvements in several health outcomes.

Interventions
Digital physician-pharmacist collaborative care
Outcomes
10-year ASCVD risk2-hour plasma glucoseBMI+10 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

Early use of effective therapies may improve diabetes outcomes

This study evaluated the cost-effectiveness of various glucose-lowering agents in type 2 diabetes patients, finding significant reductions in HbA1c levels.

Interventions
DulaglutideEmpagliflozinLiraglutide+3 more
Outcomes
BMIEstimated glomerular filtration rateHDL cholesterol+4 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs

Ertugliflozin improves cardiac function in type 2 diabetes

The study evaluated the effects of ertugliflozin on cardiac function in individuals with type 2 diabetes and pre-heart failure, finding significant improvements in certain cardiac metrics.

Interventions
Ertugliflozin
Outcomes
Adverse events incidenceGlobal longitudinal strainHbA1c+9 more
Added to Dediabetes Jul 12, 2026

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.